Evidence-Based Care
Utilizing advanced FloTrac monitoring, awake fibreoptic intubation, and stellate ganglion blocks to optimize complex oncology outcomes.
Evidence-Based Evolution
01
1940s: Initial Specialization
Establishment of specialized anaesthetic management for oncological resections, prioritizing intraoperative stability and early postoperative recovery protocols.
02
1960s: Regional Techniques
Introduction of neuraxial and peripheral nerve blocks to enhance analgesia while reducing systemic opioid requirements and associated immunosuppression.
03
1980s: Multimodal Protocols
Shift toward balanced anaesthesia, integrating non-opioid adjuncts to improve surgical outcomes and facilitate earlier mobilization in hospital settings.
04
2000s: Precision Monitoring
Implementation of goal-directed fluid therapy and advanced haemodynamic monitoring to optimize perfusion during major oncology procedures.
05
2010s: ERAS Integration
Adoption of Enhanced Recovery After Surgery (ERAS) pathways, focusing on preoperative optimization and minimally invasive anaesthetic stewardship.
06
Modern Era: Onco-Anaesthesia
Evidence-based specialty care emphasizing the intersection of anaesthetic choice and long-term oncological outcomes, including recurrence-free survival.
Modern Oncology Anaesthesia
We optimize robotic cancer surgeries via FloTrac haemodynamic monitoring and ultrasound-guided regional blocks, all while adhering to ERAS protocols for superior patient recovery.
Anaesthesia in Palliative Care
Oncology anaesthetists enhance palliative care by utilizing interventional pain techniques like stellate ganglion blocks. By employing advanced haemodynamic monitoring, such as FloTrac, we ensure patient stability, comfort, and a higher quality of life.
